Clinical and molecular correlation defines activity of physiological pathways in life-sustaining kidney xenotransplantation

DJ Firl, G Lassiter, T Hirose, R Policastro… - Nature …, 2023 - nature.com
Porcine kidney xenotransplantation is accelerating towards clinical translation. However,
despite the demonstrated ability of porcine kidneys to remove metabolic waste products …

Predictive factors for persistent hypercalcemia following parathyroidectomy in patients with persistent hyperparathyroidism after kidney transplantation: a retrospective …

BC Kim, H Kim, CH Baek, YH Kim, SJ Pak… - … Journal of Surgery, 2024 - journals.lww.com
Background: Surgery for irreversible hyperparathyroidism is the preferred management for
kidney transplant patients. The authors analyzed the factors associated with persistent …

[HTML][HTML] Etelcalcetide use During Maintenance Hemodialysis and Incidence of Parathyroidectomy After Kidney Transplantation

P Delaey, A Devresse, J Morelle, D Faitatzidou… - Kidney International …, 2024 - Elsevier
Introduction Etelcalcetide is an iv calcimimetic agent, effectively reducing parathyroid
hormone levels in patients on maintenance hemodialysis (HD). The clinical impact of …

Uso de cinacalcet en hiperparatiroidismo secundario: evaluación del estado nutricional, lipídico e inflamatorio en enfermedad renal crónica

P Villarroel Heise, L Ardiles Arnaiz… - Nutrición …, 2023 - SciELO Espana
Objetivos: analizar el efecto de la terapia con cinacalcet sobre parámetros antropométricos,
inflamatorios y lipídicos en pacientes renales con hiperparatiroidismo secundario (HPT2) …

The effect of cinacalcet on hypercalcemia in kidney transplant patients with hyperparathyroidism: systematic review and meta-analysis

H Fooladi, FV Torfi, A Khodaparast… - Journal of Renal Injury …, 2023 - journalrip.com
Introduction: Following renal transplantation, patients with end-stage renal disease develop
parathyroid dysfunction and electrolyte abnormalities, including calcium and phosphate …

[HTML][HTML] Surgical Management of Autosomal Dominant Polycystic Kidney Disease: Principles and Current Practice

BM Shrestha - JNMA: Journal of the Nepal Medical Association, 2023 - ncbi.nlm.nih.gov
Autosomal dominant polycystic kidney disease is the third most common cause of renal
failure with no definitive treatment available that can directly target the development and …

Effect of parathyroidectomy after renal transplantation on grafted kidney function within one year: a meta-analysis

F Yan, Z Sun, G Liang, C Liu, Y Niu - 2024 - researchsquare.com
Objective: Secondary hyperparathyroidism (sHPT) is a common symptom of chronic kidney
disease (CKD), and at the time of transplantation, more than two-thirds of patients with end …

Persistent hyperparathyroidism after kidney transplantation in children

HK Lee, PG Park, A Han, YH Ahn, S Min, SJ Kim, J Ha… - 2023 - researchsquare.com
Background: Most patients with chronic kidney disease develop variable degrees of
secondary hyperparathyroidism, which is resolved after kidney transplantation (KT) …

Tertiary Hyperparathyroidism

T Burton, G Meyer-Rochow - 50 Landmark Papers every Thyroid …, 2024 - taylorfrancis.com
Cruzado JM, Moreno P, Torregrosa JV, Taco O, Mast R, Gómez-Vaquero C, Polo C,
Revuelta I, Francos J, Torras J, García-Barrasa A, Bestard O, Grinyó JM. J Am Soc Nephrol …

Landmark Paper

H Nieto, N Sharma - 50 Landmark Papers every Thyroid and …, 2023 - books.google.com
Landmark Paper Page 58 CHAPTER 4 Ablation Review by Hannah Nieto and Neil Sharma
DOI: 10.1201/9781003196211-4 Landmark Paper US-GUIDED PERCUTANEOUS …